
Apnicaf Oral Solution
Marketer
Abbott
Salt Composition
Caffeine (20mg/ml)
Overview Apnicaf Oral Solution
Preterm infants experiencing apnea (characterized by recurrent breathing cessation) may be treated with the prescription medication, Apnicaf Oral Solution. This solution promotes regular respiration and diminishes episodes of interrupted breathing in premature babies. Administration is exclusively by a healthcare provider, either orally or through a gastric tube. Nursing mothers whose infants receive Apnicaf Oral Solution should avoid caffeine consumption, as it transfers to breast milk. Commonly reported side effects include agitation, sleep disturbances, headaches, lightheadedness, and tachycardia. Persistent or worsening side effects warrant immediate medical attention; your physician can offer strategies for mitigation.
Primary Ingredients of Apnicaf Oral Solution
No text provided. Please provide the text you wish me to rephrase.
Uses of Apnicaf Oral Solution
Respiratory pauses in premature infants
Major Benefits of Apnicaf Oral Solution:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Apnicaf Oral Solution:
- Restlessness
- Headache
- Dizziness
- Increased heart rate
- Insomnia (difficulty in sleeping)
How to use Apnicaf Oral Solution:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Always consult the product label for complete instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Apnicaf Oral Solution works:
Apnicaf Oral Solution is a respiratory stimulant. Its mechanism involves inhibiting adenosine and phosphodiesterase activity, thereby enhancing brain and respiratory function in preterm infants. This, in turn, lessens apnea events and promotes independent breathing.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Apnicaf Oral Solution is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Apnicaf Oral Solution during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The oral administration of Apnicaf warrants careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Taking Apnicaf Oral Solution might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Apnicaf Oral Solution in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Apnicaf Oral Solution's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Apnicaf Oral Solution :
NA
Facts to Know About Apnicaf Oral Solution
| Label | Value |
|---|---|
| Chemical Category | Methylxanthine |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | A1 and A2 adenosine receptor blocker |
